This is a preview of subscription content, log in via an institution to check access.
References
Domino EF (2010) Taming the ketamine tiger. 1965. Anesthesiology 113:678–684
Hashimoto K (2014) R-Stereoisomer of ketamine as alternative of ketamine for treatment-resistant major depression. Clin Psychopharmacol Neurosci
Hashimoto K, Malchow B, Falkai P, Schmitt A (2013) Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci 263:367–377
Hillhouse TM, Porter JH, Negus SS (2014) Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats. Psychopharmacology (Berl). doi:10.1007/s00213-014-3451-3
Krystal JH, Sanacora G, Duman RS (2013) Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry 73:1133–1141
Machado-Vieira R, Salvadore G, Diazgranados N, Zarate CA Jr (2009) Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther 123:143–150
Morgan CJ, Curran HV, Independent Scientist Committee on Drugs (2012) Ketamine use: a review. Addiction 107:27–38
Suzuki T, Aoki T, Kato H, Yamazaki M, Misawa M (1999) Effects of the 5-HT3 receptor antagonist ondansetron on the ketamine-and dizocilpine-induced place preferences ion mice. Eur J Pharmacol 385:99–102
Zhang JC, Li SX, Hashimoto K (2014) R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine. Pharmacol Biochem Behav 116:137–141
Acknowledgements
This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas of the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K.H.).
Conflict of interest
Dr. Hashimoto is an inventor on a filed patent application on “The use of R-ketamine in the treatment of psychiatric diseases” by Chiba University. Dr. Hashimoto has served as a scientific consultant to Astellas and Taisho, and he also received the research support from Abbvie, Dainippon Sumitomo, Otsuka, and Taisho. Dr. Chun Yang reports no biomedical financial interests or potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, C., Hashimoto, K. Rapid antidepressant effects and abuse liability of ketamine. Psychopharmacology 231, 2041–2042 (2014). https://doi.org/10.1007/s00213-014-3543-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-014-3543-0